| Year |
Citation |
Score |
| 2023 |
Kim SS, Liu HC, Mell LK. Treatment Considerations for Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin. Current Treatment Options in Oncology. PMID 36696081 DOI: 10.1007/s11864-023-01051-w |
0.36 |
|
| 2022 |
Yilmaz E, Ismaila N, Bauman JE, Dabney R, Gan G, Jordan R, Kaufman M, Kirtane K, McBride SM, Old MO, Rooper L, Saba N, Sheth S, Subramaniam RM, Wise-Draper TM, ... ... Mell LK, et al. Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2202328. PMID 36521102 DOI: 10.1200/JCO.22.02328 |
0.311 |
|
| 2022 |
Liu HC, Williamson CW, Zou J, Todd JR, Nelson TJ, Hill LM, Linnemeyer KE, Henderson G, Madgula P, Faung B, Sacco AG, Vitzthum LK, Weissbrod PA, Blumenfeld LS, Mell LK. Quantitative prediction of aspiration risk in head and neck cancer patients treated with radiation therapy. Oral Oncology. 136: 106247. PMID 36410204 DOI: 10.1016/j.oraloncology.2022.106247 |
0.714 |
|
| 2022 |
Kotha NV, Williamson CW, Mell LK, Murphy JD, Martinez E, Binder PS, Mayadev JS. Disparities in time to start of definitive radiation treatment for patients with locally advanced cervical cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 35428688 DOI: 10.1136/ijgc-2021-003305 |
0.554 |
|
| 2022 |
Caudell JJ, Gillison ML, Maghami E, Spencer S, Pfister DG, Adkins D, Birkeland AC, Brizel DM, Busse PM, Cmelak AJ, Colevas AD, Eisele DW, Galloway T, Geiger JL, Haddad RI, ... ... Mell LK, et al. NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022. Journal of the National Comprehensive Cancer Network : Jnccn. 20: 224-234. PMID 35276673 DOI: 10.6004/jnccn.2022.0016 |
0.381 |
|
| 2022 |
Nelson TJ, Thompson CA, Zou J, Kumar A, Sangchan P, Williamson CW, Vitzthum LK, Sharabi AB, Murphy JD, Fakhry CA, Mell LK. Validation of NRG Oncology's prognostic nomograms for oropharyngeal cancer in the Veterans Affairs database. Cancer. PMID 35194791 DOI: 10.1002/cncr.34141 |
0.685 |
|
| 2022 |
Williamson CW, Nelson T, Thompson CA, Vitzthum LK, Zakeri K, Riviere P, Bryant AK, Sharabi AB, Zou J, Mell LK. Bias Reduction through Analysis of Competing Events (BRACE) Correction to Address Cancer Treatment Selection Bias in Observational Data. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 35140122 DOI: 10.1158/1078-0432.CCR-21-2468 |
0.661 |
|
| 2021 |
Sumner W, Kim SS, Vitzthum L, Moore K, Atwood T, Murphy J, Miyauchi S, Califano JA, Mell LK, Mundt AJ, Sharabi AB. End of treatment cone-beam computed tomography (CBCT) is predictive of radiation response and overall survival in oropharyngeal squamous cell carcinoma. Radiation Oncology (London, England). 16: 147. PMID 34372887 DOI: 10.1186/s13014-021-01871-w |
0.669 |
|
| 2021 |
Nelson TJ, Javier-DesLoges J, Deka R, Courtney PT, Nalawade V, Mell L, Murphy J, Parsons JK, Rose BS. Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance. Jama Network Open. 4: e219452. PMID 33999164 DOI: 10.1001/jamanetworkopen.2021.9452 |
0.416 |
|
| 2021 |
Pang J, Faraji F, Risa E, Mell LK, Houlton JJ, Califano JA. High rates of postoperative radiotherapy delay in head and neck cancer before and after Medicaid expansion. Head & Neck. PMID 33998088 DOI: 10.1002/hed.26736 |
0.323 |
|
| 2021 |
Vitzthum LK, Nalawade V, Riviere P, Sumner W, Nelson T, Mell LK, Furnish T, Rose B, Martínez ME, Murphy JD. Racial, Ethnic, and Socioeconomic Discrepancies in Opioid Prescriptions Among Older Patients With Cancer. Jco Oncology Practice. OP2000773. PMID 33534647 DOI: 10.1200/OP.20.00773 |
0.681 |
|
| 2021 |
Javier-Desloges J, Nelson T, Courtney PT, Deka R, Nalawade V, Mell LK, Murphy JD, Parsons JK, Rose BS. PSA velocity to predict clinical progression in African American and non-Hispanic White patients with low-risk prostate cancer undergoing active surveillance. Journal of Clinical Oncology. 39: 196-196. DOI: 10.1200/JCO.2021.39.6_SUPPL.196 |
0.468 |
|
| 2020 |
Riviere P, Vitzthum LK, Nalawade V, Deka R, Furnish T, Mell LK, Rose BS, Wallace M, Murphy JD. Validation of an oncology-specific opioid risk calculator in cancer survivors. Cancer. PMID 33378556 DOI: 10.1002/cncr.33410 |
0.713 |
|
| 2020 |
Zakeri K, Rotolo F, Lacas B, Vitzthum LK, Le QT, Gregoire V, Overgaard J, Hackshaw A, Zackrisson B, Parmar MKB, Burtness BA, Ghi MG, Sanguineti G, O'Sullivan B, Fortpied C, ... ... Mell LK, et al. Predictive classifier for intensive treatment of head and neck cancer. Cancer. PMID 33017867 DOI: 10.1002/cncr.33212 |
0.704 |
|
| 2020 |
Dyer BA, Feng CH, Eskander R, Sharabi AB, Mell LK, McHale M, Mayadev JS. Current Status of Clinical Trials for Cervical and Uterine Cancer Using Immunotherapy Combined with Radiation. International Journal of Radiation Oncology, Biology, Physics. PMID 32942005 DOI: 10.1016/j.ijrobp.2020.09.016 |
0.316 |
|
| 2020 |
Small W, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, ... Mell LK, et al. NRG Oncology /RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer- An Update. International Journal of Radiation Oncology, Biology, Physics. PMID 32905846 DOI: 10.1016/J.Ijrobp.2020.08.061 |
0.315 |
|
| 2020 |
Yusufaly TI, Meyers SM, Mell LK, Moore KL. Knowledge-Based Planning for Intact Cervical Cancer. Seminars in Radiation Oncology. 30: 328-339. PMID 32828388 DOI: 10.1016/j.semradonc.2020.05.009 |
0.321 |
|
| 2020 |
Feng CH, Mell LK, Sharabi AB, McHale M, Mayadev JS. Immunotherapy With Radiotherapy and Chemoradiotherapy for Cervical Cancer. Seminars in Radiation Oncology. 30: 273-280. PMID 32828383 DOI: 10.1016/j.semradonc.2020.05.003 |
0.308 |
|
| 2020 |
Vitzthum LK, Heide ES, Park H, Williamson CW, Sheridan P, Huynh-Le MP, Sirak I, Wei L, Tarnawski R, Mahantshetty U, Nguyen C, Mayadev J, Yashar CM, Sacco AG, Mell LK. Comparison of Hematologic Toxicity and Bone Marrow Compensatory Response in Head and Neck vs. Cervical Cancer Patients Undergoing Chemoradiotherapy. Frontiers in Oncology. 10: 1179. PMID 32793487 DOI: 10.3389/fonc.2020.01179 |
0.663 |
|
| 2020 |
Pfister DG, Spencer S, Adelstein D, Adkins D, Anzai Y, Brizel DM, Bruce JY, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Galloway T, ... ... Mell LK, et al. Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 18: 873-898. PMID 32634781 DOI: 10.6004/Jnccn.2020.0031 |
0.338 |
|
| 2020 |
Simon AB, Vitzthum LK, Mell LK. Challenge of Directly Comparing Imaging-Based Diagnoses Made by Machine Learning Algorithms With Those Made by Human Clinicians. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1903350. PMID 32271670 DOI: 10.1200/Jco.19.03350 |
0.534 |
|
| 2020 |
Kim SS, Shen S, Miyauchi S, Sanders PD, Franiak-Pietryga I, Mell L, Gutkind JS, Cohen EEW, Califano JA, Sharabi AB. B-cells improve overall survival in HPV-associated squamous cell carcinomas and are activated by radiation and PD-1 blockade. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32193227 DOI: 10.1158/1078-0432.Ccr-19-3211 |
0.301 |
|
| 2020 |
Subramaniam RM, Demora L, Yao M, Yom SS, Gillison ML, Caudell JJ, Waldron J, Xia P, Chung CH, Truong M, Harrison LB, Chan J, Geiger JL, Mell L, Seaward SA, et al. 18 FDG PET/CT prediction of treatment outcomes in patients with p16-positive, non-smoking associated, locoregionally advanced oropharyngeal cancer (LA-OPC) receiving deintensified therapy: Results from NRG-HN002. Journal of Clinical Oncology. 38: 6563-6563. DOI: 10.1200/Jco.2020.38.15_Suppl.6563 |
0.318 |
|
| 2020 |
Williamson C, Vitzthum L, Zou J, Zakeri K, Sharabi A, Murphy J, Mell L. Competing Risk Analysis to Address Selection Bias in Comparative Effectiveness Research International Journal of Radiation Oncology*Biology*Physics. 108: S145-S146. DOI: 10.1016/j.ijrobp.2020.07.890 |
0.558 |
|
| 2020 |
Nelson T, Deka R, Nalawade V, Chen Q, Courtney P, Salans M, Cherry D, Luterstein E, Parsons J, Kader K, Stewart T, Mell L, Murphy J, Rose B. Association of PSA Velocity with Disease Progression and Metastases in Men with Low Risk Prostate Cancer on Active Surveillance International Journal of Radiation Oncology*Biology*Physics. 108: e881. DOI: 10.1016/j.ijrobp.2020.07.473 |
0.427 |
|
| 2020 |
Vitzthum L, Riviere P, Nelson T, Mell L, Rose B, Murphy J. Rates of New Opioid Prescription during Curative Intent Cancer Treatment by Race and Socioeconomic Status International Journal of Radiation Oncology*Biology*Physics. 108: S98-S99. DOI: 10.1016/j.ijrobp.2020.07.2272 |
0.631 |
|
| 2019 |
Vitzthum LK, Riviere P, Sheridan P, Nalawade V, Deka R, Furnish T, Mell LK, Rose B, Wallace M, Murphy JD. Predicting Persistent Opioid Use, Abuse and Toxicity Among Cancer Survivors. Journal of the National Cancer Institute. PMID 31754696 DOI: 10.1093/Jnci/Djz200 |
0.672 |
|
| 2019 |
Vitzthum LK, Park H, Zakeri K, Heide ES, Nalawade V, Mundt AJ, Vaida F, Murphy JD, Mell LK. Risk of Pelvic Fracture with Radiation Therapy in Older Patients. International Journal of Radiation Oncology, Biology, Physics. PMID 31610251 DOI: 10.1016/J.Ijrobp.2019.10.006 |
0.67 |
|
| 2019 |
Vitzthum LK, Park H, Zakeri K, Bryant AK, Feng C, Shen H, Cohen EEW, Murphy JD, Mell LK. Selection of Head and Neck Cancer Patients for Intensive Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 31580929 DOI: 10.1016/J.Ijrobp.2019.09.011 |
0.736 |
|
| 2019 |
Mell LK, Shen H, Nguyen-Tan PF, Rosenthal DI, Zakeri K, Vitzthum LK, Frank SJ, Schiff PB, Trotti A, Bonner JA, Jones CU, Yom SS, Thorstad WL, Wong S, Shenouda G, et al. Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31420360 DOI: 10.1158/1078-0432.Ccr-19-1832 |
0.718 |
|
| 2019 |
Cohen EEW, Bell RB, Bifulco CB, Burtness B, Gillison ML, Harrington KJ, Le QT, Lee NY, Leidner R, Lewis RL, Licitra L, Mehanna H, Mell LK, Raben A, Sikora AG, et al. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC). Journal For Immunotherapy of Cancer. 7: 184. PMID 31307547 DOI: 10.1186/s40425-019-0662-5 |
0.303 |
|
| 2019 |
Huynh-Le MP, Klapheke A, Cress R, Mell LK, Yashar CM, Einck JP, Mundt AJ, Mayadev JS. Impact of marital status on receipt of brachytherapy and survival outcomes in locally advanced cervical cancer. Brachytherapy. 18: 612-619. PMID 31153760 DOI: 10.1016/j.brachy.2019.04.273 |
0.318 |
|
| 2019 |
Park A, Alabaster A, Shen H, Mell LK, Katzel JA. Undertreatment of women with locoregionally advanced head and neck cancer. Cancer. PMID 31090932 DOI: 10.1002/cncr.32187 |
0.383 |
|
| 2019 |
Adelstein DJ, Ismaila N, Ku JA, Burtness B, Swiecicki PL, Mell L, Beitler JJ, Gross N, Jones CU, Kaufman M, Le QT, Semrad TJ, Siu LL, Ridge JA. Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer: ASCO Provisional Clinical Opinion. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900441. PMID 31021656 DOI: 10.1200/Jco.19.00441 |
0.35 |
|
| 2019 |
Vitzthum L, Riviere P, Sheridan P, Nalawade V, Deka R, Xu R, Mell LK, Wallace M, Murphy JD. Predicting Persistent Opioid Use, Abuse and Toxicity Among Cancer Survivors International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.524 |
0.677 |
|
| 2019 |
Vitzthum L, Park H, Zakeri K, Sojourner E, Nalawade V, Mundt A, Murphy J, Mell L. Risk of Pelvic Fracture by Type of Radiation Therapy in Older Patients International Journal of Radiation Oncology*Biology*Physics. 105: S217. DOI: 10.1016/J.Ijrobp.2019.06.299 |
0.664 |
|
| 2019 |
Sacco A, Sharabi A, Jing Z, Pittman E, Gold K, Sumner W, Califano J, Brumund K, Orosco R, Rash D, Coffey C, Cohen E, Mell L. Radiotherapy with Concurrent and Adjuvant Pembrolizumab in Patients with P16-Positive Locoregionally Advanced Head and Neck Cancer: KEYCHAIN Trial Lead-In Results International Journal of Radiation Oncology*Biology*Physics. 105: E363-E364. DOI: 10.1016/j.ijrobp.2019.06.1701 |
0.361 |
|
| 2018 |
Vitzthum LK, Feng CH, Noticewala S, Hines PJ, Nguyen C, Zakeri K, Sojourner EJ, Shen H, Mell LK. Comparison of Comorbidity and Frailty Indices in Patients With Head and Neck Cancer Using an Online Tool. Jco Clinical Cancer Informatics. 1-9. PMID 30652602 DOI: 10.1200/CCI.18.00082 |
0.681 |
|
| 2018 |
Zakeri K, Panjwani N, Carmona R, Shen H, Vitzthum LK, Zhang QE, Murphy JD, Mell LK. Generalized Competing Event Models Can Reduce Cost and Duration of Cancer Clinical Trials. Jco Clinical Cancer Informatics. 1-12. PMID 30652559 DOI: 10.1200/CCI.17.00124 |
0.69 |
|
| 2018 |
Zakeri K, Noticewala SS, Vitzthum LK, Sojourner E, Shen H, Mell LK. 'Optimism bias' in contemporary national clinical trial network phase III trials: are we improving? Annals of Oncology : Official Journal of the European Society For Medical Oncology. 29: 2135-2139. PMID 30412223 DOI: 10.1093/Annonc/Mdy340 |
0.602 |
|
| 2018 |
Green G, Kim E, Carmona R, Shen H, Murphy JD, Mell LK. Incidence of Long-Term Esophageal Dilation With Various Treatment Approaches in the Older Head and Neck Cancer Population. Frontiers in Oncology. 8: 466. PMID 30406032 DOI: 10.3389/Fonc.2018.00466 |
0.452 |
|
| 2018 |
Vitzthum LK, Mell LK. The role of p16 as a biomarker in nonoropharyngeal head and neck cancer. Oncotarget. 9: 33247-33248. PMID 30279955 DOI: 10.18632/oncotarget.26053 |
0.656 |
|
| 2018 |
Bryant AK, Huynh-Le MP, Simpson DR, Mell LK, Gupta S, Murphy JD. Intensity Modulated Radiation Therapy Versus Conventional Radiation for Anal Cancer in the Veterans Affairs System. International Journal of Radiation Oncology, Biology, Physics. 102: 109-115. PMID 30102186 DOI: 10.1016/J.Ijrobp.2018.05.044 |
0.491 |
|
| 2018 |
Bryant AK, Kader AK, McKay RR, Einck JP, Mell LK, Mundt AJ, Kane CJ, Efstathiou JA, Murphy JD, Rose BS. Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 29891203 DOI: 10.1016/J.Ijrobp.2018.04.023 |
0.477 |
|
| 2018 |
Bryant AK, Sojourner EJ, Vitzthum LK, Zakeri K, Shen H, Nguyen C, Murphy JD, Califano JA, Cohen EEW, Mell LK. Prognostic Role of p16 in Nonoropharyngeal Head and Neck Cancer. Journal of the National Cancer Institute. PMID 29878161 DOI: 10.1016/J.Ijrobp.2017.12.037 |
0.676 |
|
| 2018 |
Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, ... ... Mell LK, et al. NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018. Journal of the National Comprehensive Cancer Network : Jnccn. 16: 479-490. PMID 29752322 DOI: 10.6004/Jnccn.2018.0026 |
0.304 |
|
| 2018 |
Mayadev J, Klapheke A, Yashar C, Hsu IC, Kamrava M, Mundt AJ, Mell LK, Einck J, Benedict S, Valicenti R, Cress R. Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California. Gynecologic Oncology. PMID 29709291 DOI: 10.1016/j.ygyno.2018.04.563 |
0.337 |
|
| 2018 |
Boero IJ, Paravati AJ, Hou J, Gillespie EF, Schoenbrunner A, Unkart J, Wallace AM, Einck JP, Mell LK, Murphy JD. The Impact of Surgeons on the Likelihood of Mastectomy in Breast Cancer. Annals of Surgery. PMID 29465454 DOI: 10.1097/Sla.0000000000002698 |
0.414 |
|
| 2018 |
Park A, Albaster A, Shen H, Mell LK, Katzel JA. Are women with head and neck cancer undertreated? Journal of Clinical Oncology. 36: LBA6002-LBA6002. DOI: 10.1200/JCO.2018.36.18_SUPPL.LBA6002 |
0.357 |
|
| 2018 |
Zakeri K, Rotolo F, Lacas B, Vitzthum LK, Le Q, Gregoire V, Overgaard J, Tobias J, Zackrisson B, Parmar MK, Burtness BA, Ghi MG, Sanguineti G, O'Sullivan B, Fortpied C, ... ... Mell LK, et al. Predictor of effectiveness of treatment intensification on overall survival in head and neck cancer (HNC). Annals of Oncology. 29. DOI: 10.1093/Annonc/Mdy287.008 |
0.347 |
|
| 2018 |
O'Hare C, Bryant A, Mell L, Murphy J. Impact of HIV Status on Treatment Outcomes in Head and Neck Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e287. DOI: 10.1016/J.Ijrobp.2018.07.915 |
0.462 |
|
| 2018 |
Feng C, Vitzthum L, Sojourner E, Zakeri K, Nguyen C, Straka C, Mell L. Assessment of Interrater Reliability for Comorbidity Indices in Determining Eligibility for Treatment Intensification in Head and Neck Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e197-e198. DOI: 10.1016/J.Ijrobp.2018.07.707 |
0.666 |
|
| 2018 |
Sojourner E, Park H, Feng C, Vitzthum L, Sirak I, Wei L, Tarnawski R, Mahantshetty U, Mell L. Variation in Hematologic Toxicity in Patients Undergoing Radiation Therapy with Concurrent Weekly Cisplatin for Head and Neck Versus Cervical Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e636. DOI: 10.1016/J.Ijrobp.2018.07.1735 |
0.695 |
|
| 2018 |
Vitzthum L, Feng C, Zakeri K, Sojourner E, Murphy J, Mell L. Patterns of Care Among Elderly US Veterans Treated for Head and Neck Cancer with Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 102: e359-e360. DOI: 10.1016/J.Ijrobp.2018.07.1083 |
0.717 |
|
| 2017 |
Bryant AK, Mudgway R, Huynh-Le MP, Simpson DR, Mell LK, Gupta S, Sharabi AB, Murphy JD. Effect of CD4 Count on Treatment Toxicity and Tumor Recurrence in Human Immunodeficiency Virus-Positive Patients With Anal Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 29102276 DOI: 10.1016/J.Ijrobp.2017.09.034 |
0.487 |
|
| 2017 |
Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, ... ... Mell LK, et al. NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017. Journal of the National Comprehensive Cancer Network : Jnccn. 15: 761-770. PMID 28596256 DOI: 10.6004/Jnccn.2017.0101 |
0.355 |
|
| 2017 |
Beriwal S, Klopp A, Mell L. Defining Prognostic Biomarkers and Optimal Adjuvant Treatment for Gynecologic Cancer. International Journal of Radiation Oncology, Biology, Physics. 98: 1-4. PMID 28586944 DOI: 10.1016/J.Ijrobp.2017.01.014 |
0.397 |
|
| 2017 |
Li N, Noticewala SS, Williamson CW, Shen H, Sirak I, Tarnawski R, Mahantshetty U, Hoh CK, Moore KL, Mell LK. Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 123: 325-330. PMID 28528206 DOI: 10.1016/j.radonc.2017.02.017 |
0.306 |
|
| 2017 |
Boero IJ, Gillespie EF, Hou J, Paravati AJ, Kim E, Einck JP, Yashar C, Mell LK, Murphy JD. The Impact of Radiation Oncologists on the Early Adoption of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer. International Journal of Radiation Oncology, Biology, Physics. 97: 571-580. PMID 28126306 DOI: 10.1016/J.Ijrobp.2016.11.009 |
0.486 |
|
| 2017 |
Mell LK, Sirák I, Wei L, Tarnawski R, Mahantshetty U, Yashar CM, McHale MT, Xu R, Honerkamp-Smith G, Carmona R, Wright M, Williamson CW, Kasaová L, Li N, Kry S, et al. Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2). International Journal of Radiation Oncology, Biology, Physics. 97: 536-545. PMID 28126303 DOI: 10.1016/J.Ijrobp.2016.11.027 |
0.339 |
|
| 2017 |
Bryant AK, Banegas M, Martinez ME, Mell LK, Murphy JD. Trends in radiation therapy among cancer survivors in the United States, 2000-2030. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28096199 DOI: 10.1158/1055-9965.Epi-16-1023 |
0.56 |
|
| 2017 |
Mell LK, Sirak I, Portelance L, Wolfson AH, Stewart AJ, Sharma D, Princ D, Mahantshetty U, Nakamura M, Hirata K, Kry SF, Wei L, Xu R, Zakeri K, Sojourner E, et al. Phase III randomized trial of image-guided bone marrow-sparing intensity modulated radiation therapy (IG-BMS-IMRT) for locoregionally advanced cervical cancer: The INTERTECC-3 trial. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.Tps5600 |
0.316 |
|
| 2017 |
Mell L, Zhang Q, Shen H, Nguyen-Tan P, Rosenthal D, Zakeri K, Frank S, Schiff P, Trotti A, Bonner J, Jones C, Yom S, Thorstad W, Wong S, Shenouda G, et al. Generalized Competing Event Regression to Stratify Head and Neck Cancer Patients: Secondary Analysis of NRG Oncology RTOG 9003, 0129, and 0522 International Journal of Radiation Oncology*Biology*Physics. 99: S236-S237. DOI: 10.1016/J.Ijrobp.2017.06.578 |
0.37 |
|
| 2017 |
Vitzthum L, Noticewala S, Hines P, Zakeri K, Nguyen C, Shen H, Mell L. A Web-Based Tool to Compare Comorbidity Models and Geriatric Risk-Assessment in Head and Neck Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 99: E379. DOI: 10.1016/J.Ijrobp.2017.06.1508 |
0.674 |
|
| 2016 |
Acevedo JR, Fero KE, Wilson B, Sacco AG, Mell LK, Coffey CS, Murphy JD. Cost-Effectiveness Analysis of Elective Neck Dissection in Patients With Clinically Node-Negative Oral Cavity Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27551113 DOI: 10.1200/Jco.2016.68.4563 |
0.486 |
|
| 2016 |
Yashar CM, Beriwal S, Klopp A, Mell L. Progress in Vulvar and Endometrial Cancers: Exploiting Anatomy and Biology and Improving Systemic Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: 1-5. PMID 27511840 DOI: 10.1016/J.Ijrobp.2016.02.048 |
0.4 |
|
| 2016 |
Roeland EJ, Triplett DP, Matsuno RK, Boero IJ, Hwang L, Yeung HN, Mell L, Murphy JD. Patterns of Palliative Care Consultation Among Elderly Patients With Cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 14: 439-45. PMID 27059192 DOI: 10.6004/Jnccn.2016.0050 |
0.489 |
|
| 2016 |
Boero IJ, Paravati AJ, Triplett DP, Hwang L, Matsuno RK, Gillespie EF, Yashar CM, Moiseenko V, Einck JP, Mell LK, Parikh SA, Murphy JD. Modern Radiation Therapy and Cardiac Outcomes in Breast Cancer. International Journal of Radiation Oncology, Biology, Physics. 94: 700-8. PMID 26972642 DOI: 10.1016/J.Ijrobp.2015.12.018 |
0.49 |
|
| 2016 |
Song T, Li N, Zarepisheh M, Li Y, Gautier Q, Zhou L, Mell L, Jiang S, Cerviño L. An Automated Treatment Plan Quality Control Tool for Intensity-Modulated Radiation Therapy Using a Voxel-Weighting Factor-Based Re-Optimization Algorithm. Plos One. 11: e0149273. PMID 26930204 DOI: 10.1371/Journal.Pone.0149273 |
0.304 |
|
| 2016 |
Carmona R, Zakeri K, Green G, Hwang L, Gulaya S, Xu B, Verma R, Williamson CW, Triplett DP, Rose BS, Shen H, Vaida F, Murphy JD, Mell LK. Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing Events. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26884579 DOI: 10.1200/Jco.2015.65.0739 |
0.502 |
|
| 2016 |
Boero IJ, Paravati AJ, Xu B, Cohen EE, Mell LK, Le QT, Murphy JD. Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26729432 DOI: 10.1200/Jco.2015.63.9898 |
0.522 |
|
| 2016 |
Boero I, Paravati A, Matsuno R, Gillespie E, Einck J, Mell L, Murphy J. EP-1452: The impact of individual surgeons on the likelihood of mastectomy in breast cancer Radiotherapy and Oncology. 119: S673. DOI: 10.1016/S0167-8140(16)32702-5 |
0.509 |
|
| 2015 |
Boero IJ, Paravati AJ, Triplett DP, Hwang L, Matsuno RK, Mell LK, Murphy JD. The impact of radiotherapy costs on clinical outcomes in breast cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 26472317 DOI: 10.1016/J.Radonc.2015.10.004 |
0.456 |
|
| 2015 |
Paravati AJ, Boero IJ, Triplett DP, Hwang L, Matsuno RK, Xu B, Mell LK, Murphy JD. Variation in the Cost of Radiation Therapy Among Medicare Patients With Cancer. Journal of Oncology Practice / American Society of Clinical Oncology. 11: 403-9. PMID 26265172 DOI: 10.1200/Jop.2015.005694 |
0.484 |
|
| 2015 |
Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, ... ... Mell LK, et al. Head and Neck Cancers, Version 1.2015. Journal of the National Comprehensive Cancer Network : Jnccn. 13: 847-56. PMID 26150579 DOI: 10.6004/Jnccn.2015.0102 |
0.325 |
|
| 2015 |
Li Y, Hoisak JD, Li N, Jiang C, Tian Z, Gautier Q, Zarepisheh M, Wu Z, Liu Y, Jia X, Hattangadi-Gluth J, Mell LK, Jiang S, Murphy JD. Dosimetric benefit of adaptive re-planning in pancreatic cancer stereotactic body radiotherapy. Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists. PMID 26002122 DOI: 10.1016/J.Meddos.2015.04.002 |
0.419 |
|
| 2015 |
Xu B, Boero IJ, Hwang L, Le QT, Moiseenko V, Sanghvi PR, Cohen EE, Mell LK, Murphy JD. Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer. Cancer. 121: 1303-11. PMID 25537836 DOI: 10.1002/Cncr.29207 |
0.561 |
|
| 2015 |
Spiotto MT, Cao H, Mell L, Toback FG. Angiotensin-converting enzyme inhibitors predict acute kidney injury during chemoradiation for head and neck cancer. Anti-Cancer Drugs. 26: 343-9. PMID 25486599 DOI: 10.1097/Cad.0000000000000191 |
0.34 |
|
| 2015 |
Carmona R, Green GB, Zakeri K, Gulaya S, Xu B, Verma R, Williamson C, Rose BS, Murphy JD, Vaida F, Mell LK. Novel method to stratify elderly patients with head and neck cancer. Journal of Clinical Oncology. 33: 9534-9534. DOI: 10.1200/Jco.2015.33.15_Suppl.9534 |
0.508 |
|
| 2015 |
Carmona R, Zakeri K, Green GB, Triplett DP, Murphy JD, Mell LK. Novel method to stratify elderly patients with prostate cancer. Journal of Clinical Oncology. 33: 9532-9532. DOI: 10.1200/Jco.2015.33.15_Suppl.9532 |
0.505 |
|
| 2015 |
Marhoon Z, Borgan S, Zakeri K, Mell L. Analysis of composite endpoints in gene expression studies in oncology Bmc Proceedings. 9: 1-1. DOI: 10.1186/1753-6561-9-S1-A17 |
0.348 |
|
| 2015 |
Hwang L, Boero I, Triplett D, Matsuno R, Xu B, Gillespie E, Mell L, Murphy J. Outcomes of Hypofractionated Versus Standard Fractionated Breast Cancer Radiation in the Real World: A Population-Based Analysis International Journal of Radiation Oncology*Biology*Physics. 93: E40-E41. DOI: 10.1016/J.Ijrobp.2015.07.644 |
0.474 |
|
| 2015 |
Boero I, Xu B, Mell L, Le Q, Murphy J. Impact of Radiation Oncologist Provider Volume on Clinical Outcomes in Head and Neck Cancer International Journal of Radiation Oncology*Biology*Physics. 93: S127. DOI: 10.1016/J.Ijrobp.2015.07.304 |
0.524 |
|
| 2015 |
Carmona R, Hwang L, Green G, Zakeri K, Murphy J, Mell L. Competing Event Models Improve Risk Stratification of Elderly Breast Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 93: S118. DOI: 10.1016/J.Ijrobp.2015.07.282 |
0.485 |
|
| 2015 |
Zakeri K, Carmona R, Green G, Murphy J, Mell L. Competing Event Models Reduce Clinical Trial Costs in Elderly Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 93: E365. DOI: 10.1016/J.Ijrobp.2015.07.1479 |
0.475 |
|
| 2015 |
Boero I, Paravati A, Hwang L, Triplett D, Matsuno R, Xu B, Mell L, Murphy J. The Impact of Cost on Clinical Outcomes After Radiation Therapy for Breast Cancer International Journal of Radiation Oncology*Biology*Physics. 93: E362. DOI: 10.1016/J.Ijrobp.2015.07.1470 |
0.489 |
|
| 2015 |
Carmona R, Green G, Eren A, Eren M, Murphy J, Mell L. Cost-Effectiveness of Gemcitabine Plus Cisplatin and Intensity Modulated Radiation Therapy for Patients With Locally Advanced Cervical Cancer International Journal of Radiation Oncology*Biology*Physics. 93: E361. DOI: 10.1016/J.Ijrobp.2015.07.1468 |
0.526 |
|
| 2015 |
Green G, Carmona R, Hwang L, Murphy J, Mell L. Risk Factors for Esophageal Dilation in the Elderly Head and Neck Cancer Population International Journal of Radiation Oncology*Biology*Physics. 93: E299. DOI: 10.1016/J.Ijrobp.2015.07.1301 |
0.514 |
|
| 2014 |
Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, ... ... Mell LK, et al. Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 12: 1454-87. PMID 25313184 DOI: 10.6004/Jnccn.2014.0142 |
0.352 |
|
| 2014 |
Wong J, Xu B, Yeung HN, Roeland EJ, Martinez ME, Le QT, Mell LK, Murphy JD. Age disparity in palliative radiation therapy among patients with advanced cancer. International Journal of Radiation Oncology, Biology, Physics. 90: 224-30. PMID 25195994 DOI: 10.1016/J.Ijrobp.2014.03.050 |
0.526 |
|
| 2014 |
Carmona R, Gulaya S, Murphy JD, Rose BS, Wu J, Noticewala S, McHale MT, Yashar CM, Vaida F, Mell LK. Validated competing event model for the stage I-II endometrial cancer population. International Journal of Radiation Oncology, Biology, Physics. 89: 888-98. PMID 24969798 DOI: 10.1016/J.Ijrobp.2014.03.047 |
0.505 |
|
| 2014 |
Yeung HN, Mitchell WM, Roeland EJ, Xu B, Mell LK, Le QT, Murphy JD. Palliative radiation before hospice: the long and the short of it. Journal of Pain and Symptom Management. 48: 1070-9. PMID 24819083 DOI: 10.1016/J.Jpainsymman.2014.04.004 |
0.455 |
|
| 2014 |
Call JA, Prendergast BM, Jensen LG, Ord CB, Goodman KA, Jacob R, Mell LK, Thomas CR, Jabbour SK, Miller RC. Intensity-modulated Radiation Therapy for Anal Cancer: Results From a Multi-Institutional Retrospective Cohort Study. American Journal of Clinical Oncology. PMID 24401669 DOI: 10.1097/COC.0000000000000009 |
0.341 |
|
| 2014 |
Zakeri K, MacEwan I, Vazirnia A, Cohen EE, Spiotto MT, Haraf DJ, Vokes EE, Weichselbaum RR, Mell LK. Race and competing mortality in advanced head and neck cancer. Oral Oncology. 50: 40-4. PMID 24134948 DOI: 10.1016/J.Oraloncology.2013.09.012 |
0.329 |
|
| 2014 |
Paravati A, Xu B, Mell L, Murphy J. Sources of Variation in the Cost of Radiation Therapy for Breast, Lung, and Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S63. DOI: 10.1016/J.Ijrobp.2014.05.215 |
0.469 |
|
| 2014 |
Xu B, Le Q, Sanghvi P, Mell L, Murphy J. Aspiration Pneumonia After Chemoradiation Therapy for Head and Neck Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S564. DOI: 10.1016/J.Ijrobp.2014.05.1705 |
0.55 |
|
| 2013 |
Sutterley C, Gautier Q, Graves Y, Zarepisheh M, Li N, Tian Z, Jia X, Moore K, Rahn D, Murphy J, Mell L, Jiang S. MO-A-137-10: Evaluation of A GPU-Based In-House Automatic Re-Planning System for Adaptive Radiotherapy Re-Planning for Head and Neck Cancer. Medical Physics. 40: 389. PMID 28518350 DOI: 10.1118/1.4815213 |
0.554 |
|
| 2013 |
Simpson DR, MartÃnez ME, Gupta S, Hattangadi-Gluth J, Mell LK, Heestand G, Fanta P, Ramamoorthy S, Le QT, Murphy JD. Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer. Journal of the National Cancer Institute. 105: 1814-20. PMID 24231453 DOI: 10.1093/jnci/djt318 |
0.493 |
|
| 2013 |
Murphy JD, Nelson LM, Chang DT, Mell LK, Le QT. Patterns of care in palliative radiotherapy: a population-based study. Journal of Oncology Practice / American Society of Clinical Oncology. 9: e220-7. PMID 23943892 DOI: 10.1200/Jop.2012.000835 |
0.366 |
|
| 2013 |
Mundt AJ, Yashar C, Mell L, Mayr N, Milosevic M. Oncology scan - gynecological cancers: new treatments, old treatments, imaging, and meta-analyses. International Journal of Radiation Oncology, Biology, Physics. 86: 207-10. PMID 23643375 DOI: 10.1016/J.Ijrobp.2013.01.026 |
0.371 |
|
| 2013 |
Gu X, Dong B, Wang J, Yordy J, Mell L, Jia X, Jiang SB. A contour-guided deformable image registration algorithm for adaptive radiotherapy. Physics in Medicine and Biology. 58: 1889-901. PMID 23442596 DOI: 10.1088/0031-9155/58/6/1889 |
0.306 |
|
| 2013 |
Jensen LG, Hasselle MD, Rose BS, Nath SK, Hasan Y, Scanderbeg DJ, Yashar CM, Mundt AJ, Mell LK. Outcomes for patients with cervical cancer treated with extended-field intensity-modulated radiation therapy and concurrent cisplatin. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 23: 119-25. PMID 23262521 DOI: 10.1097/Igc.0B013E3182749114 |
0.323 |
|
| 2013 |
Song T, Li N, Graves Y, Gautier Q, Zarepisheh M, Li Y, Mundt A, Zhou L, Moore K, Yashar C, Mell L, Jia X, Jiang S, Cervino L. SU-E-T-718: Automatic IMRT Plan Quality Control for GYN Cancer Clinical Trials Medical Physics. 40: 371-371. DOI: 10.1118/1.4815145 |
0.326 |
|
| 2013 |
Gulaya S, Carmona R, Zakeri K, Vaida F, Mell L. Population-Based Study of Comorbidity and Noncancer Mortality in Head-and-Neck Cancer International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.1312 |
0.411 |
|
| 2013 |
Carmona R, Gulaya S, Lu T, Wu J, Yashar C, Mell L. Risk Stratification for Non-Cancer Mortality in Early Stage Endometrial Cancer International Journal of Radiation Oncology*Biology*Physics. 87: S42. DOI: 10.1016/J.IJROBP.2013.06.111 |
0.311 |
|
| 2012 |
Simpson DR, Song WY, Moiseenko V, Rose BS, Yashar CM, Mundt AJ, Mell LK. Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin. International Journal of Radiation Oncology, Biology, Physics. 83: e81-6. PMID 22516388 DOI: 10.1016/J.Ijrobp.2011.12.012 |
0.322 |
|
| 2012 |
Zhu H, Dadachanji KK, Zakeri K, Hasan Y, Yashar C, Mell L. Longitudinal Study of Acute Hematologic Function in Cervical Cancer Patients Treated With Chemoradiation Therapy International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.051 |
0.44 |
|
| 2011 |
Hasselle MD, Rose BS, Kochanski JD, Nath SK, Bafana R, Yashar CM, Hasan Y, Roeske JC, Mundt AJ, Mell LK. Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. International Journal of Radiation Oncology, Biology, Physics. 80: 1436-45. PMID 20708346 DOI: 10.1016/j.ijrobp.2010.04.041 |
0.303 |
|
| 2011 |
Jiang S, Gu X, Jia X, Men C, Gautier Q, Uribe-Sanchez A, Mell L, Mundt A. TH-C-BRA-01: Online Adaptive Radiotherapy: Technical Barriers and Potential Solutions Medical Physics. 38: 3852-3852. DOI: 10.1118/1.3613502 |
0.305 |
|
| 2011 |
Liang Y, Mell L, Kim G. WE‐C‐BRB‐09: Volumetric Modulated Arc Therapy Based Total Marrow Irradiation and Dosimetry Verification Medical Physics. 38: 3806-3806. DOI: 10.1118/1.3613328 |
0.31 |
|
| 2011 |
Jensen L, Hasselle M, Rose B, Nath S, Hasan Y, Yashar C, Mundt A, Mell L. Outcomes For Cervical Cancer Patients Treated With Extended Field Intensity Modulated Radiation Therapy And Concurrent Cisplatin International Journal of Radiation Oncology*Biology*Physics. 81: S452-S453. DOI: 10.1016/J.IJROBP.2011.06.970 |
0.335 |
|
| 2011 |
Song S, Dorn P, Hasselle M, Mell L, Kochanski J, Mundt A, Hasan Y. Adverse Effect of Radiation Delay in Locally Advanced Cervical Cancer in the Setting of Definitive Concurrent Chemoradiation International Journal of Radiation Oncology*Biology*Physics. 81: S185-S186. DOI: 10.1016/J.IJROBP.2011.06.331 |
0.314 |
|
| 2010 |
Rose BS, Nath SK, Lu S, Mell LK. Competing mortality in advanced head and neck cancer: A population-based study. Journal of Clinical Oncology. 28: 5578-5578. DOI: 10.1200/jco.2010.28.15_suppl.5578 |
0.307 |
|
| 2009 |
Devisetty K, Mell LK, Salama JK, Schomas DA, Miller RC, Jani AB, Roeske JC, Aydogan B, Chmura SJ. A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 93: 298-301. PMID 19717198 DOI: 10.1016/J.Radonc.2009.07.006 |
0.315 |
|
| 2009 |
Liang Y, Rose B, Lewis J, Yashar C, Mundt A, Mell L. WE‐E‐BRD‐01: Investigating Effects of Pelvic Bone Marrow Radiation Dose On Acute Hematologic Toxicity Using High Dimensional Data Analysis Medical Physics. 36: 2781-2781. DOI: 10.1118/1.3182553 |
0.328 |
|
| 2009 |
Tyagi N, Mell L, Jiang S, Mundt A. TU‐D‐BRC‐01: Repeated Measures Analysis of Variance of Patient Specific Daily Margins to Assess Interfraction Motion for Cervical Cancer Patients Undergoing IMRT Using Daily CBCT Imaging Medical Physics. 36: 2733-2734. DOI: 10.1118/1.3182376 |
0.386 |
|
| 2009 |
Song W, Huh S, Liang Y, White G, Yashar C, Nichols R, Mundt A, Mell L. Dosimetric Comparison Study between Intensity Modulated Radiation Therapy and Three-dimensional Conformal Proton Therapy for Treatment of Cervical Cancer International Journal of Radiation Oncology*Biology*Physics. 75: S359. DOI: 10.1016/J.Ijrobp.2009.07.822 |
0.423 |
|
| 2008 |
Salama JK, Stenson KM, List MA, Mell LK, Maccracken E, Cohen EE, Blair E, Vokes EE, Haraf DJ. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer. Archives of Otolaryngology--Head & Neck Surgery. 134: 1060-5. PMID 18936351 DOI: 10.1001/archotol.134.10.1060 |
0.328 |
|
| 2008 |
Mell LK, Mundt AJ. Intensity-modulated radiation therapy in gynecologic cancers: growing support, growing acceptance. Cancer Journal (Sudbury, Mass.). 14: 198-9. PMID 18536560 DOI: 10.1097/PPO.0b013e318178dda1 |
0.336 |
|
| 2008 |
Tyagi N, Lewis J, Vo D, Yashar C, Mell L, Mundt A, Jiang S. WE‐E‐AUD C‐03: Determining An Appropriate Margin Around CTV to Account for Interfraction Motion During IMRT for Cervical Cancer Patients Based On Daily Imaging Medical Physics. 35: 2955-2955. DOI: 10.1118/1.2962784 |
0.363 |
|
| 2008 |
Tiryaki H, Ahn K, Roeske J, Mundt A, Mell L, Aydogan B. SU-GG-T-71: Dosimetric Comparison of Bone Marrow-Sparing Intensity Modulated Radiation Theraphy Versus Conventional Techniques for the Treatment of Cervical Cancer Medical Physics. 35: 2742-2742. DOI: 10.1118/1.2961822 |
0.362 |
|
| 2008 |
Mell L, Dignam J, Salama J, Cohen E, Polite B, Bhate A, Haraf D, Mittal B, Vokes E, Weichselbaum R. Factors Associated with Non-cancer Mortality in Advanced Head and Neck Cancer: A Competing Risks Analysis International Journal of Radiation Oncology*Biology*Physics. 72: S42. DOI: 10.1016/J.IJROBP.2008.06.859 |
0.367 |
|
| 2007 |
Mell LK, Weichselbaum RR. More on cetuximab in head and neck cancer. The New England Journal of Medicine. 357: 2201-2; author reply. PMID 18032774 DOI: 10.1056/NEJMC071540 |
0.364 |
|
| 2007 |
Salama JK, Mell LK, Schomas DA, Miller RC, Devisetty K, Jani AB, Mundt AJ, Roeske JC, Liauw SL, Chmura SJ. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 4581-6. PMID 17925552 DOI: 10.1200/JCO.2007.12.0170 |
0.353 |
|
| 2007 |
Aydogan B, Ahn K, Tiryaki H, Kochanski J, Mundt A, Roeske J, Mell L. Bone Marrow-Sparing Intensity Modulated Radiation Therapy Versus Conventional Techniques in Cervical Cancer Patients International Journal of Radiation Oncology*Biology*Physics. 69: S401. DOI: 10.1016/J.Ijrobp.2007.07.1528 |
0.302 |
|
| 2006 |
Devisetty K, Mell LK, Salama JK, Jani AB, Mundt AJ, Roeske J, Aydogan B, Chmura SJ. 2138 : Anal Cancer Treated With Intensity Modulated Radiation Therapy (IMRT) and Concurrent Chemotherapy: A Dosimetric Analysis of Acute Gastrointestinal Toxicity International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.542 |
0.326 |
|
| 2005 |
Kochanski J, Mehta N, Mell L, Roeske J, Sutton H, Mundt A. Outcome of Cervical Cancer Patients Treated with Intensity Modulated Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 63: S214. DOI: 10.1016/J.IJROBP.2005.07.368 |
0.351 |
|
| 2004 |
Kochanski JD, Roeske JC, Mell LK, Yamada SD, Mehta N, Mundt AJ. Outcome of FIGO stage I-II cervical cancer patients treated with intensity modulated pelvic radiation therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 5027. PMID 28015517 DOI: 10.1200/jco.2004.22.14_suppl.5027 |
0.31 |
|
| 2004 |
Kochanski JD, Roeske JC, Mell LK, Yamada SD, Mehta N, Mundt AJ. Outcome of FIGO stage I-II cervical cancer patients treated with intensity modulated pelvic radiation therapy Journal of Clinical Oncology. 22: 5027-5027. DOI: 10.1200/JCO.2004.22.90140.5027 |
0.323 |
|
| 2004 |
Mell L, Fyles A, Small W, Creutzberg C, Jhingran A, Arcangeli G, Varia M, Hatano K, De Los Santos J, Barillot I, Roeske J, Mundt A. Adjuvant intensity modulated pelvic radiation therapy in gynecologic malignancies: Survey of the gynecologic IMRT working group International Journal of Radiation Oncology*Biology*Physics. 60: S215-S216. DOI: 10.1016/J.Ijrobp.2004.06.167 |
0.336 |
|
| Show low-probability matches. |